Repertoire of gluten peptides active in celiac disease patients: Perspectives for translational therapeutic applications

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 2, 2012, Pages 207-219

  Camarca, Alessandra ^a,b   del Mastro, Andrea ^b   Gianfrani, Carmen ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Celiac disease; Glutn epitopes; T cells assays

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GLIADIN; GLUTEN; GLUTENIN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; PROLAMIN;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CELLULAR IMMUNITY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENOTYPE; GLUTEN FREE DIET; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE MUCOSA; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PROTEIN DEGRADATION; REVIEW; RNA TRANSLATION; WHEAT;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; EPITOPES; GLUTENS; HLA ANTIGENS; HORDEUM; HUMANS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; PREVALENCE; SECALE CEREALE; TRANSLATIONAL MEDICAL RESEARCH; TRITICUM;

EID: 84861120545     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012800493549     Document Type: Review

References (89)

1. Mustalahti, K.; Catassi, C.; Reunanen, A.; Fabiani, E.; Heier, M.; McMillan, S.; Murray, L.; Metzger, M.H.; Gasparin, M.; Bravi, E. and Mäki, M. (2010) Coeliac EU Cluster, Project Epidemiology. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann. Med., 42, 587-595.
2. Fasano, A.; Berti, I.; Gararduzzi, T.; Not, T.; Colletti, R.B.; Drago, S.; Elitsur, Y.; Green, P.H.; Guandalini, S.; Hill, I.D.; Pietzak, M.; Ventura, A.; Thrope, M.; Kryszak, D.; Fornaioli, F.; Wasserman, S.S.; Murray, J.A. and Horvath, K. (2005) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch. Intern. Med., 163, 286-292.
3. Maki, M.; Mustalahti, K.; Kokkonen, J.; Kulmala, P.; Haapalahti, M.; Karttunen, T.; Ilonen, J.; Laurila, K.; Dahlbom, I.; Hansson, T.; Höpfl, P. and Knip, M. (2003) Prevalence of celiac disease among children in Finland. N. Engl. J. Med., 348, 2517-2524.
4. Tommasini, A.; Not, T.; Kiren, V.; Baldas, V.; Santon, D.; Trevisiol, C.; Berti, I.; Neri, E.; Gerarduzzi, T.; Bruno, I.; Lenhardt, A.; Zamuner, E.; Spanò, A.; Crovella, S.; Martellossi, S.; Torre, G.; Sblattero, D.; Marzari, R.; Bradbury, A.; Tamburlini, G. and Ventura, A. (2004) Mass screening for celiac disease using anti-human transglutaminase antibody assay. Arch. Dis. Child, 89, 512-515.
5. West, J.; Logan, R.F.; Hill, P.G.; Lloyd, A.; Lewis, S.; Hubbard, R.; Reader, R.; Holmes, G.K. and Khaw, K.T. (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut, 52, 960-965.
6. Catassi, C.; Ratsch, I.M.; Gandolfi, L.; Pratesi, R.; Fabiani, E.; El Asmar, R.; Frijia, M.; Bearzi, I. and Vizzoni, L. (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet, 354, 647-648.
7. Lohi, S.; Mustalahti, K.; Kaukinen, K.; Laurila, K.; Collin, P.; Rissanen, H.; Lohi, O.; Bravi, E.; Gasparin, M.; Reunanen, A. and Mäki, M. (2007) Increasing prevalence of coeliac disease over time. Aliment. Pharmacol. Ther., 26, 1217-1225.
8. Biagi, F.; Klersy, C.; Balduzzi, D. and Corazza, G.R. (2010) Are we not over-estimating the prevalence of coeliac disease in the general population? Ann. Med., 42, 557-561.
9. Vilppula, A.; Kaukinen, K.; Luostarinen, L.; Krekela, I.; Patrikainen, H.; Valve, R.; Maki, M. and Collin, P. (2009) Increasing prevalence and high incidence of celiac disease in elderly people: a population based study. BMC Gastroenterol., 29, 49.
10. Troncone, R.; Ivarsson, A.; Szajewska, H. and Mearins, M.L. (2008) Review article: future research on coeliac disease-a position report from the European multistakeholder platform on celiac disease (CDEUSSA). Aliment. Pharmacol. Ther., 27, 1030-1043.
11. Rewers, M. (2005) Epidemiology of celiac disease: what are the prevalence, incidence and progression of celiac disease? Gatroenterology, 128, S47-S51.
12. Fasano, A. (2005) Clinical presentation of celiac disease in the pediatric population. Gastroenterology, 128, S68-S73.
13. Hoffenberg, E.J.; Emery, L.M.; Barriga, K.J.; Bao, F.; Taylor, J.; Eisenbarth, G.S.; Haas, J.E.; Sokol, R.J.; Taki, I.; Norris, J.M. and Rewers, M. (2004) Clinical features of children with screeningidentified evidence of celiacdisease. Pediatrics, 113, 1254-1259.
14. Brar, P.; Kwon, G.Y.; Egbuna, I.I.; Holleran, S.; Ramakrishnan, R.; Bhagat, G. and Green, P.H. (2007) Lack of correlation of degree of villous atrophy with severity of clinical presentation of celiac disease. Dig. Liver Dis., 39, 26-29.
15. Paparo, F.; Petrone, E.; Tosco, A.; Maglio, M.; Borrelli, M.; Salvati, V.M.; Miele, E.; Greco, L.; Auricchio, S. and Troncone, R. (2005) Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am. J. Gastroenterol., 100, 2294-2298.
16. Al-Toma, A.; Verbeek, W.H.; Hadithi, M.; von Blomberg, B.M. and Mulder, C.J. (2007) Survival in refractory coeliac disease and enteropathy associated T-cell lymphoma: retrospective evaluation of single centre experience. Gut, 56, 1373-1378.
17. Schuppan, D.; Dennis, M.D. and Kelly, C.P. (2005) Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management. Nutr. Clin. Care., 8, 54-69.
18. May-Ling Tjon, J.; van Bergen, J. and Koning, F. (2010) Celiac disease: how complicated can it get? Immunogenetics, 62, 641-651.
19. Malamut, G.; Afchain, P.; Verkarre, V.; Lecomte, T.; Amiot, A.; Damotte, D.; Bouhnik, Y.; Colombel, J.F.; Delchier, J.C.; Allez, M.; Cosnes, J.; Lavergne-Slove, A.; Meresse, B.; Trinquart, L.; Macintyre, E.; Radford-Weiss, I.; Hermine, O.; Brousse, N.; Cerf-Bensussan, N. and Cellier, C. (2009) Presentation and longterm follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology, 136, 81-90.
20. Verdu, E.F.; Armstrong, D.; Chir, B. and Murray, J.A. (2009) Between celiac disease and irritable bowel Syndrome: the "no man's land" of gluten sensitivity. Am. J. Gastroenterol., 104, 1587-1594.
21. Sollid, L.M., and Lie, B.A. (2005) Celiac disease genetics: current concepts and practical applications. Clin Gast. Hepatol., 3, 843-851.
22. Nistico, L.; Fagnani, C.; Coto, I.; Percopo, S.; Cotichini, R.; Limongelli, M.G.; Paparo, F.; D'Alfonso, S.; Giordano, M.; Sferlazzas, C.; Magazzu, G.; Momigliano-Richiardi, P.; Greco, L. and Stazi, M.A. (2006) Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut, 55, 803-808.
23. Dube, C.; Rostom, A.; Sy, R.; Cranney, A.; Saloojee, N.; Garritty, C.; Sampson, M.; Zhang, L.; Yazdi, F.; Mamaladze, V.; Pan, I.; Macneil, J.; Mack, D.; Patel, D. and Moher, D. (2005) The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology, 128, S57-S67.
24. Karell, K.; Louka, A.S.; Moodie, S.J.; Ascher, H.; Clot, F.; Greco, L.; Ciclitira, P.J.; Sollid, L.M. and Partanen, J. (2003) HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol., 64, 469-477.
25. van Heel, D.A.; Hunt, K.; Greco, L. and Wijmenga, C. (2005) Genetics in coeliac disease. Best Pract. Res. Clin. Gastroenterol., 19, 323-339.
26. Greco, L.; Babron, M.C.; Corazza, G.R.; Percopo, S.; Sica, R.; Clot, F.; Fulchignoni-Lataud, M.C.; Zavattari, P.; Momigliano-Richiardi, P.; Casari, G.; Gasparini, P.; Tosi, R.; Mantovani, V.; De, V.S.; Iacono, G.; D'Alfonso, A.; Selinger-Leneman, H.; Lemainque, A.; Serre, J.L. and Clerget-Darpoux, F. (2001) Existence of a genetic risk factor on chromosome 5q in Italian coeliac disease families. Ann. Hum. Genet., 65, 35-41.
27. van Belzen, M.J.; Meijer, J.W.; Sandkuijl, L.A.; Bardoel, A.F.; Mulder, C.J.; Pearson, P.L.; Houwen, R.H. and Wijmenga, C. (2003) A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology, 125, 1032-1041.
28. Dubois, P.C.; Trynka, G.; Franke, L.; Hunt, K.A.; Romanos, J.; Curtotti, A.; Zhernakova, A.; Heap, G.A.; Adany, R.; Aromaa, A.; Bardella, M.T.; van den Berg, L.H.; Bockett, N.A.; de la Concha, E.G.; Dema, B.; Fehrmann, R.S.; Fernandez-Arquero, M.; Fiatal, S.; Grandone, E.; Green, P.M.; Groen, H.J.; Gwilliam, R.; Houwen, R.H.; Hunt, S.E.; Kaukinen, K.; Kelleher, D.; Korponay-Szabo, I.; Kurppa, K.; Macmathuna, P.; Maki, M.; Mazzilli, M.C.; McCann, O.T.; Mearin, M.L.; Mein, C.A.; Mirza, M.M.; Mistry, V.; Mora, B.; Morley, K.I.; Mulder, C.J.; Murray, J.A.; Nunez, C.; Oosterom, E.; Ophoff, R.A.; Polanco, I.; Peltonen, L.; Platteel, M.; Rybak, A.; Salomaa, V.; Schweizer, J.J.; Sperandeo, M.P.; Tack, G.J.; Turner, G.; Veldink, J.H.; Verbeek, W.H.; Weersma, R.K.; Wolters, V.M.; Urcelay, E.; Cukrowska, B.; Greco, L.; Neuhausen, S.L.; McManus, R.; Barisani, D.; Deloukas, P.; Barrett, J.C.; Saavalainen, P.; Wijmenga, C. and van Heel, D.A. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet., 42, 295-302.
29. Silano, M. and De Vincenzi, M. (1999) Bioactive antinutritional peptides derived from cereal prolamins: a review. Nahrung, 3, 175-184.
30. Wieser, H. (2007) Chemistry of gluten proteins. Food Microbiol., 24, 115-119.
31. Stene, L.C.; Honeyman, M.C.; Hoff enberg, E.J.; Haas, J.E.; Sokol, R.J.; Emery, L.; Taki, I.; Norris, J.M.; Erlich, H.A.; Eisenbarth, G.S. and Rewers, M. (2006) Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol., 101, 2333-2340.
32. Zanoni, G.; Navone, R.; Lunardi, C.; Tridente, G.; Bason, C.; Sivori, S.; Beri, R.; Dolcino, M.; Valletta, E.; Corrocher, R. and Puccetti, A. (2006) In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med., 3, 1637-1653.
33. Forsberg, G.; Fahlgren, A.; Horstedt, P.; Hammarstrom, S.; Hernell, O. and Hammarstrom, M.L. (2004) Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am. J. Gastroenterol., 99, 894-904.
34. Ivarsson, A.; Hernell, O.; Stenlund, H. and Persson, L.A. (2002) Breast-feeding protects against celiac disease. Am. J. Clin. Nutr., 75, 914-921.
35. Cammarota, G.; Cuoco, L.; Cianci, R.; Pandolfi, F. and Gasbarrini, G. (2000) Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet, 356, 1494-1495.
36. Lundin, K.E.; Scott, H.; Hansen, T.; Paulsen, G.; Halstensen, T.S.; Fausa, O.; Thorsby, E. and Sollid, L.M. (1993) Gliadin-specific, HLA-DQ(a1*0501, b1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med., 178, 187-196.
37. Molberg, O.; McAdam, S.N.; Korner, R.; Quarsten, H.; Kristiansen, C.; Madsen, L.; Fugger, L.; Scott, H.; Noren, O.; Roepstorff, P.; Lundin, K.E.; Sjostrom, H. and Sollid, L.M. (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gutderived T cells in celiac disease. Nat. Med., 4, 713-717.
38. van de Wal, Y.; Kooy, Y.; van Veelen, P.A.; Peña, S.; Mearin, L.; Papadopoulos, G. and Koning, F. (1998a) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol., 161, 1585-1588.
39. Vader, W.; Kooy, Y.; Van Vellen, P.; De Ru, A.; Harris, D.; Benckhuijsen, W.; Pena, S.; Mearin, L.; Drijfhout, J.W. and Koning, F. (2002). The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology, 122, 1729-1737.
40. Hovhannisyan, Z.; Weiss, A.; Martin, A.; Wiesner, M.; Tollefsen, S.; Yoshida, K.; Ciszewski, C.; Curran, S.A.; Murray, J.A.; David, C.S.; Sollid, L.M.; Koning, F.; Teyton, L. and Jabry, B. (2008) The role of HLA-DQ8 b57 polymorphism in the anti-gluten T-cell response in celiac disease. Nature, 456, 534-538.
41. Nilsen, E.M.; Jahnsen, F.L.; Lundin, K.E.; Johansen, F.E.; Fausa, O.; Sollid, L.M.; Jahnsen, J.; Scott, H. and Brandtzaeg, P. (1998) Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology,115, 551-563.
42. Mazzarella, G.; MacDonald, T.T.; Salvati, V.M.; Mulligan, P.; Pasquale, L.; Stefanile, R.; Lionetti, P.; Auricchio, S.; Pallone, F.; Troncone, R. and Monteleone, G. (2003) Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions. Am. J. Pathol., 162, 1845-1855.
43. Monteleone, I.; Monteleone, G.; Del Vecchio Blanco, G.; Vavassori, P.; Cucchiara, S.; MacDonald, T.T. and Pallone, F. (2004) Regulation of the T helper cell type 1 transcription factor Tbet in coeliac disease mucosa. Gut, 53, 1090-1095.
44. Fina, D.; Sarra, M.; Fantini, M.C.; Rizzo, A.; Caruso, R.; Caprioli, F.; Stolfi, C.; Cardolini, I.; Dottori, M.; Boirivant, M.; Pallone, F.; Macdonald, T.T. and Monteleone, G. (2008) Regulation of gut inflammation and th17 cell response by interleukin-21. Gastroenterology, 134, 1038-1048.
45. Bodd, M.; Ráki, M.; Tollefsen, S.; Fallang, L.E.; Bergseng, E.; Lundin, K.E. and Sollid, L.M. (2010) HLA-DQ2-restricted glutenreactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol., 3, 594-601.
46. De Nitto, D.; Monteleone, I.; Franzè, E.; Pallone, F. and Monteleone, G. (2009) Involvement of interleukin-15 and interleukin-21, two g-chain-related cytokines, in celiac disease. World J. Gastroenterol., 15, 4609-4614.
47. Monteleone, I.; Sarra, M.; Del Vecchio Blanco, G.; Paoluzi, O.A.; Franzè, E.; Fina, D.; Fabrizi, A.; MacDonald, T.T.; Pallone, F. and Monteleone, G. (2010) Characterization of IL-17A-producing cells in celiac disease mucosa. J. Immunol., 184, 2211-2218.
48. Fernandez, S.; Molina, I.J.; Romero, P.; Gonzales, R.; Pena, J.; Sanchez, F.; Reynoso, F.R.; Perez-Navero, J.L.; Estevez, O.; Ortega, C. and Santamaria, M. (2011) Characterization of Gliadin-Specific Th17 Cells from Mucosa of Celiac Disease Patients. Am. J. Gastroenterol., 106, 528-538.
49. Gianfrani, C.; Troncone, R.; Magione, P.; Casentini, E.; De Pascale, M.; Faruolo, C.; Senger, S.; Terrazzano, G.; Southwood, S.; Auricchio, S. and Sette, A. (2003) Celiac disease association with CD8+ T cell responses: identification of a novel gliadinderived HLA-A2-restricted epitope. J. Immunol., 170, 2719-2726.
50. Mazzarella, G.; Stefanile, R.; Camarca, A.; Giliberti, P.; Casentini, E.; Marano, C.; Iaquinto, G.; Giardullo, N.; Auricchio, S.; Sette, A.; Troncone, R. and Gianfrani, C. (2008) Gliadin activates HLA Class-I restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosys. Gatroenterology, 134, 1017-1027.
51. Jabri, B. and Ebert, E. (2007) Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue. Immunol. Rev., 215, 202-214.
52. Meresse, B.; Chen, Z.; Ciszewski, C.; Tretiakova, M.; Bhagat, G.; Krausz, T.N.; Raulet, D.H.; Lanier, L.L.; Groh, V.; Spies, T.; Ebert, E.C.; Green, P.H. and Jabri, B. (2004) Coordinated induction by IL15 of a TCR independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity, 21, 357-366.
53. Meresse, B.; Curran, S.A.; Ciszewski, C.; Orbelyan, G.; Setty, M.; Bhagat, G.; Lee, L.; Tretiakova, M.; Semrad, C.; Kistner, E.; Winchester, R.J.; Braud, V.; Lanier, L.L.; Geraghty, D.E.; Green, P.H.; Guandalini, S. and Jabri, B. (2006) Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med., 203, 1343-1355.
54. Mention, J.J.; Ben Ahmed, M.; Bègue, B.; Barbe, U.; Verkarre, V.; Asnafi, V.; Colombel, J.F.; Cugnenc, P.H.; Ruemmele, F.M.; McIntyre, E.; Brousse, N.; Cellier, C. and Cerf-Bensussan, N. (2003) Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology, 125, 730-745.
55. Maiuri, L.; Ciacci, C.; Auricchio, S.; Brown, V.; Quaratino, S. and Londei, M. (2000) Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology, 119, 996-1006.
56. Maiuri, L.; Ciacci, C.; Ricciardelli, I.; Vacca, L.; Raia, V.; Auricchio, S.; Picard, J.; Osman, M.; Quaratino, S. and Londei, M. (2003) Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet, 362, 30-37.
57. Hue, S.; Mention, J.J.; Montiero, R.C.; Zang, S.L.; Cellier, C.; Schmitz, J.; Verkarre, V.; Fodil, N.; Bahram, S.; Cerf-Bensussan, N. and Caillat-Zucman, S. (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity, 21, 367-377.
58. De Ritis, G.; Auricchio, S.; Jones, H.W.; Lew, E.; Bernardin, J.E. and Kasarda, D.D. (1988) In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology, 94, 41-49.
59. Barone, M.; Gimigliano, A.; Castoria, G.; Paolella, G.; Maurano, F.; Paparo, F.; Maglio, M.; Mineo, A.; Miele, E.; Nanayakkara, M.; Troncone, R. and Auricchio, S. (2007) Growth factor like activity of gliadin an alimentary protein: implications for celiac disease. Gut, 56, 480-488.
60. Kim, C.Y.; Quarsten, H.; Bergseng, E.; Khosla, C. and Sollid, L.M. (2004) Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. USA, 101, 4175-4179.
61. Moustakas, A.K.; van de Wal, Y.; Routsias, J.; Kooy, Y.M.; van Veelen, P.; Rrjfhout, J.W.; Koning, F.; Papadopoulos, G.K. (2000) Structure of celiac disease-associated HLA-DQ8 and nonassociated HLA-DQ9 allelles in complex with two disease-specific epitopes. Int. Immunol., 12, 1157-1166.
62. Vartdal, F.; Johansen, B.H.; Friede, T.; Thorpe, C.J.; Stevanović, S.; Eriksen, J.E.; Sletten, K.; Thorsby, E.; Rammensee, H.G. and Sollid, L.M. (1996) The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. J. Immunol., 26, 2764-2672.
63. Qiao, S.W.; Bergseng, E.; Molberg, O.; Jung, G.; Fleckenstein, B. and Sollid, L.M. (2005) Refining the rules of gliadin T cell epitope binding to the disease associated DQ2 molecules in celiac disease: importance of proline spacing and glutamine deamidation. J. Immunol., 175, 254-261.
64. Bergseng, E.; Xia, J.; Kim, C.Y.; Khosla, C. and Sollid, L.M. (2005) Main chain Hydrogen bond interactions in the binding of praline rich gluten peptides to the celiac disesase associated HLADQ2 molecule. J. Biol. Chem., 280, 21791-21796.
65. Arentz-Hansen, H.; McAdam, S.N.; Molberg, Ø.; Fleckenstein, B.; Lundin, K.E.; Jørgensen, T.J.; Jung, G.; Roepstorff, P. and Sollid, L.M. (2002) Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology, 123, 803-809.
66. Sjöström, H.; Lundin, K.E.; Molberg, O.; Körner, R.; McAdam, S.N.; Anthonsen, D.; Quarsten, H.; Norén, O.; Roepstorff, P.; Thorsby, E. and Sollid, L.M. (1998) Identification of a gliadin Tcell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol., 48, 111-115.
67. Henderson, K.N.; Tye-Din, J.A.; Reid, H.H.; Chen, Z.; Borg, N.A.; Beissbarth, T.; Tatham, A.; Mannering, S.I.; Purcell, A.W.; Dudek, N.L.; van Heel, D.A.; McCluskey, J.; Rossjohn, J. and Anderson, R.P. (2007) A Structural and Immunological Basis for the Role of Human Leukocyte Antigen DQ8 in Celiac Disease. Immunity, 27, 23-34.
68. Mamone, G.; Ferranti, P.; Melck, D.; Tafuro, F.; Longobardo, L.; Chianese, L. and Addeo, F. (2004) Susceptibility to transglutaminase of gliadin peptides predicted by a mass spectrometrybased assay. FEBS Lett., 562, 177-182.
69. Dørum, S.; Arntzen, M. Ø.; Qiao, S.W.; Holm, A.; Koehler, C.J.; Thiede, B.; Sollid, L.M. and Fleckenstein, B. (2010) The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. PLoS One., 19, e14056.
70. Vader, L.W.; Stepniak, D.T.; Bunnik, E.M.; Kooy, Y.M.; de Haan, W.; Drijfhout, J.W.; Van Veelen, P.A.; and Koning, F. (2003) Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology, 125, 1105-1113.
71. Anderson, R.P.; Degano, P.; Godkin, A.J.; Jewell, D.P. and Hill, A.V.S. (2000) In vivo antigen challenge in celiac disease identifies a single transglutaminase-modifies peptide as the dominant Agliadin T-cell epitope. Nat. Med., 6, 337-342.
72. Tye-Din, J.A.; Stewart, J.A.; Dromey, J.A.; Beissbarth, T.; van Heel, D.A.; Tatham, A.; Henderson, K.; Mannering, S.I.; Gianfrani, C.; Jewell, D.P.; Hill, A.V.S.; McCluskey, J.; Rossjohn, J. and Anderson, R.P. (2010) Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Science Trans. Med., 2, 41-51.
73. Shan, L.; Molberg, Ø.; Parrot, I.; Hausch, F.; Filiz, F.; Gray, G.M.; Sollid, L.M. and Khosla C. (2002) Structural basis for gluten intolerance in celiac sprue. Science, 297, 2275-2279.
74. Qiao, S.W.; Bergseng, E.; Molberg, Ø.; Xia, J.; Fleckenstein, B.; Khosla, C.; Sollid, L.M. (2004) Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion. J. Immunol., 173, 1757-1762.
75. Camarca, A.; Anderson, R.P.; Mamone, G.; Fierro, O.; Facchiano, A.; Facchiano, A.; Costantini, S.; Zanzi, D.; Sidney, J.; Auricchio, S.; Sette, A.; Troncone, R. and Gianfrani, C. (2009) Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J. Immunol., 182, 4158-4166.
76. Tollefsen, S.; Arentz-Hansen, H.; Fleckenstein, B.; Molberg, O.; Raki, M.; Kwok, W.; Jung, G.; Lundin, K.E.A. and Sollid, L.M. (2006) HLA-DQ2 and DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest., 116, 2226-2236.
77. van de Wal, Y.; Kooy, Y.M.; van Veelen, P.A.; Peña, S.A.; Mearin, L.M.; Molberg, O.; Lundin, K.E.; Sollid, L.M.; Mutis, T.; Benckhuijsen, W.E.; Drijfhout, J.W. and Koning, F. (1998b) Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl. Acad. Sci. USA, 95, 10050-10054.
78. van de Wal, Y.; Kooy, Y.M.; van Veelen, P.; Vader, W.; August, S.A.; Drijfhout, J.W.; Peña, S.A. and Koning, F. (1999) Glutenin is involved in the gluten-driven mucosal T cell response. Eur. J. Immunol., 29, 3133-3139.
79. Gianfrani, C.; Auricchio, S.; and Troncone, R. Possible drug targets for celiac disease. (2006) Expert Opin. Ther. Targets, 10, 601-611.
80. Molberg, O.; Uhlen, A.K.; Jensen, T.; Flaete, N.S.; Fleckenstein, B.; Arentz-Hansen, H.; Raki, M.; Lundin, K.E. and Sollid, L.M. (2005) Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology, 128, 393-401.
81. Mitea, C.; Salentjin, E.M.; van Veelen, P.; Goryunova, S.V.; van der Meer, I.M.; van den Broeck, H.C.; Mujico, J.R.; Monserrat, V.; Gilissen, L.J.; Drijfhout, J.W.; Dekking, L.; Koning, F. and Smulders, M.J. (2010) A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease. PLoS One, 5, e15637.
82. Jil-Humanes, J.; Pistón, F.; Tollefsen, S.; Sollid, L.M.; Barro, F. (2010) Effective shutdown in the expression of celiac diseaserelated wheat gliadin T-cell epitopes by RNA interference. Proc. Natl. Acad. Sci. USA, 107, 17023-17028.
83. Larchè, M. and Wraith, D.C. (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med., 11, S69-76.
84. Larchè, M. (2007) Immunotherapy with allergen peptides. Allergy Asthma Clin. Immunol., 3, 53-59.
85. Akdis, M.; Verhagen, J.; Taylor, A.; Karamloo F.; Karagiannidis, C.; Crameri, R.; Thunberg, S.; Deniz, G.; Valenta, R; Fiebig, H.; Kegel, C.; Disch, R; Schmidt-Weber, C.B.; Blaser, K. and Akdis, C.A. (2004) Immune responses in healthy and allergic individuals are characterized by a fine balance between allergenspecific T regulatory 1 and T helper 2 cells. J. Exp. Med., 199, 1567-1575.
86. Jäger, A. and Kuchroo, V.K. (2010) Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol., 72, 173-184.
87. Campbell, J.D.; Buckland, K.F.; McMillan, S.J.; Kearley, J.; Oldfield, W.L.; Stern, L.J.; Grönlund, H.; van Hage, M.; Reynolds, C.J.; Boyton, R.J.; Cobbold, S.P.; Kay, A.B.; Altmann, D.M.; Lloyd, C.M. and Larché, M. (2009) Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J. Exp. Med., 206, 1535-1547.
88. Wraith, D.C. (2009) Therapeutic peptide vaccines for treatment of autoimmune diseases. Immunol. Lett., 122, 134-136.
89. Shan, L.; Quiao, S.W.; Arentz-Hansen, H.; Molberg, O.; Gray, G.M.; Sollid, L.M. and Khosla, C. (2005) Iolentification and analysis of multivalent proteolytically resistant peptides form gluten: implication for celiac sprue. J. Proteome Res., 4, 1732-1741.